ARCELLX INC's ticker is and the CUSIP is 03940C100. A total of 50 filers reported holding ARCELLX INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,687,101 | +10.1% | 102,762 | -2.9% | 0.40% | +17.5% |
| Q2 2023 | $3,347,356 | -45.0% | 105,862 | -46.4% | 0.34% | -48.6% |
| Q1 2023 | $6,084,297 | -17.1% | 197,478 | -16.7% | 0.66% | -11.8% |
| Q4 2022 | $7,341,578 | -48.1% | 236,978 | -68.6% | 0.74% | -50.6% |
| Q3 2022 | $14,149,000 | -32.5% | 753,833 | -35.3% | 1.51% | -42.1% |
| Q2 2022 | $20,953,000 | +26.1% | 1,165,533 | -3.7% | 2.60% | +106.2% |
| Q1 2022 | $16,619,000 | – | 1,209,876 | – | 1.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 5,500,007 | $169,455,216 | 63.12% |
| NEA Management Company, LLC | 4,745,262 | $146,201,522 | 10.11% |
| Samsara BioCapital, LLC | 909,579 | $28,024,129 | 5.79% |
| Paradigm Biocapital Advisors LP | 1,757,779 | $54,157,171 | 5.13% |
| Soleus Capital Management, L.P. | 1,248,147 | $38,455,409 | 3.98% |
| Perceptive Advisors | 3,841,739 | $118,363,979 | 3.50% |
| Cormorant Asset Management, LP | 1,600,000 | $49,296 | 3.25% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,398,321 | $73,892,270 | 3.12% |
| Altium Capital Management LP | 150,000 | $4,621,500 | 2.56% |
| Novo Holdings A/S | 1,225,000 | $37,742,250 | 2.49% |